Page last updated: 2024-10-30

kynurenic acid and Dyskinesia, Medication-Induced

kynurenic acid has been researched along with Dyskinesia, Medication-Induced in 4 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Research Excerpts

ExcerptRelevanceReference
"Kynurenic acid (KYNA) is a neuroactive metabolite that interacts with NMDA, AMPA/kainate and alpha 7 nicotinic receptors."1.42The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level. ( Bohar, Z; Horvath, G; Kekesi, G; Pardutz, A; Petrovszki, Z; Safrany-Fark, A; Tar, L; Tuboly, G; Vecsei, L, 2015)
"This relationship is altered in Parkinsonism and in levodopa-induced dyskinesias (LID), resulting in an upregulation of corticostriatal glutamatergic function."1.33Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys. ( Bédard, PJ; Grégoire, L; Guidetti, P; Izzo, E; Rassoulpour, A; Samadi, P; Schwarcz, R, 2005)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tuboly, G1
Tar, L1
Bohar, Z1
Safrany-Fark, A1
Petrovszki, Z1
Kekesi, G1
Vecsei, L1
Pardutz, A1
Horvath, G1
Samadi, P2
Grégoire, L2
Rassoulpour, A2
Guidetti, P2
Izzo, E2
Schwarcz, R2
Bédard, PJ2
Di Paolo, T1
Robertson, RG1
Farmery, SM1
Sambrook, MA1
Crossman, AR1

Other Studies

4 other studies available for kynurenic acid and Dyskinesia, Medication-Induced

ArticleYear
The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level.
    Brain research bulletin, 2015, Volume: 112

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Disease Models, Animal; Dose-Response

2015
Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:7

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dose-

2005
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
    Behavioural brain research, 2008, Jan-25, Volume: 186, Issue:2

    Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Drug Interactions; Dyskines

2008
Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus.
    Brain research, 1989, Jan-09, Volume: 476, Issue:2

    Topics: Animals; Dyskinesia, Drug-Induced; Globus Pallidus; Kynurenic Acid; Macaca fascicularis; Receptors,

1989